AJP - Heart Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (December 19, 2008). doi:10.1152/ajpheart.00448.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/2/H396    most recent
00448.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Naitoh, K.
Right arrow Articles by Shimamoto, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Naitoh, K.
Right arrow Articles by Shimamoto, K.
Submitted on April 28, 2008
Revised on November 26, 2008
Accepted on December 17, 2008

Roles of Cx43-associated protein kinases in suppression of gap junction-mediated chemical coupling by ischemic preconditioning

Kazuyuki Naitoh, Toshiyuki Yano, Tetsuji Miura1*, Takahito Ito, Takayuki Miki, Masaya Tanno2, Takahiro Sato, Hiroyuki Hotta, Yoshiaki Terashima, and Kazuaki Shimamoto

1 Sapporo Medical University School of Medicine
2 Sapporo Medical University

* To whom correspondence should be addressed. E-mail: miura{at}sapmed.ac.jp.

Ischemic preconditioning (PC) suppresses chemical coupling of cardiomyocytes via gap junctions (GJs) during ischemia, which is an adjunct mechanism of protection. The aim of this study was to characterize roles of protein kinases in PC-induced GJ modulation. In isolated rat hearts, ventricular tissues were sampled before and after ischemia with or without PC, and intercalated disc-rich fractions were separated for immunoprecipitation and immunoblotting. Levels of protein kinase C-{varepsilon} (PKC{varepsilon}), p38mitogen-activated protein kinase-{alpha} (p38MAPK{alpha}) and Src co-immunoprecipitated with connexin-43 (Cx43) were increased after ischemia, whereas p38MAPK{beta} was not detected in the Cx43 immunoprecipitates. PC did not modify the level of Cx43-Src complex after ischemia. However, PC enhanced Cx43-PKC{varepsilon} complex formation, which was abolished by PKC{varepsilon} translocation inhibitory peptide (PKC{varepsilon}-TIP). In contrast, PC reduced Cx43-p38MAPK{alpha} complex level and p38MAPK activity in the Cx43 immunoprecipitates after ischemia. The effect of PC on Cx43-p38MAPK{alpha} interaction was mimicked by SB203580, a p38MAPK inhibitor. PC reduced permeability of GJs to Lucifer yellow in the myocardium at 25 min after ischemia, and this effect was abolished by PKC{varepsilon}-TIP. SB203580 increased the GJ permeability at 15 min after ischemia compared with that in untreated controls, but the difference became insignificant 25 min after ischemia. In conclusion, PC has distinct effects on interaction of GJ Cx43 with PKC{varepsilon}, p38MAPK{alpha} and Src during ischemia. Suppression of GJ permeability during ischemia by PC is primarily achieved by enhanced interaction of Cx43 with PKC{varepsilon}, which overwhelms the counter-balancing effect of reduced Cx43-p38MAPK{alpha} interaction.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.